| Product NDC: | 57619-300 |
| Proprietary Name: | Nazil |
| Non Proprietary Name: | Naphazoline Hydrochloride |
| Active Ingredient(s): | .2 mg/mL & nbsp; Naphazoline Hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 57619-300 |
| Labeler Name: | LABORATORIOS SOPHIA, S.A. DE C.V. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part349 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100412 |
| Package NDC: | 57619-300-01 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 PACKAGE (57619-300-01) > 15 mL in 1 BOTTLE, PLASTIC |
| NDC Code | 57619-300-01 |
| Proprietary Name | Nazil |
| Package Description | 1 BOTTLE, PLASTIC in 1 PACKAGE (57619-300-01) > 15 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 57619-300 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Naphazoline Hydrochloride |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20100412 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | LABORATORIOS SOPHIA, S.A. DE C.V. |
| Substance Name | NAPHAZOLINE HYDROCHLORIDE |
| Strength Number | .2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |